Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies.

Weisler R, Montgomery SA, Earley WR, Szamosi J, Eriksson H.

J Clin Psychiatry. 2014 May;75(5):520-7. doi: 10.4088/JCP.13m08624.

PMID:
24816198
2.

Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.

Katila H, Mezhebovsky I, Mulroy A, Berggren L, Eriksson H, Earley W, Datto C.

Am J Geriatr Psychiatry. 2013 Aug;21(8):769-84. doi: 10.1016/j.jagp.2013.01.010. Epub 2013 Feb 6.

PMID:
23567397
4.

Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.

Weisler RH, Montgomery SA, Earley WR, Szamosi J, Lazarus A.

Int Clin Psychopharmacol. 2012 Jan;27(1):27-39. doi: 10.1097/YIC.0b013e32834d6f91.

PMID:
22027845
5.

Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.

Liebowitz M, Lam RW, Lepola U, Datto C, Sweitzer D, Eriksson H.

Depress Anxiety. 2010 Oct;27(10):964-76. doi: 10.1002/da.20740.

PMID:
20734365
6.

Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.

Bauer M, Dell'osso L, Kasper S, Pitchot W, Dencker Vansvik E, Köhler J, Jørgensen L, Montgomery SA.

J Affect Disord. 2013 Oct;151(1):209-19. doi: 10.1016/j.jad.2013.05.079. Epub 2013 Jun 27.

PMID:
23810357
7.

Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder.

Locklear JC, Svedsäter H, Datto C, Endicott J.

J Affect Disord. 2013 Jul;149(1-3):189-95. doi: 10.1016/j.jad.2013.01.021. Epub 2013 Apr 29.

PMID:
23639212
8.

Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.

Bauer M, McIntyre RS, Szamosi J, Eriksson H.

Int J Neuropsychopharmacol. 2013 Sep;16(8):1755-65. doi: 10.1017/S146114571300031X. Epub 2013 May 14.

PMID:
23672772
9.

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.

Bauer M, Demyttenaere K, El-Khalili N, Thase ME, Papakostas GI, Szamosi J, Earley WR, Eriksson H.

Int Clin Psychopharmacol. 2014 Jan;29(1):16-25. doi: 10.1097/YIC.0000000000000011.

PMID:
24108148
10.

Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.

Montgomery SA, Altamura AC, Katila H, Datto C, Szamosi J, Eriksson H.

Int Clin Psychopharmacol. 2014 Mar;29(2):93-105. doi: 10.1097/YIC.0000000000000007.

PMID:
24162081
11.

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.

El-Khalili N, Joyce M, Atkinson S, Buynak RJ, Datto C, Lindgren P, Eriksson H.

Int J Neuropsychopharmacol. 2010 Aug;13(7):917-32. doi: 10.1017/S1461145710000015. Epub 2010 Feb 23.

PMID:
20175941
12.

Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression.

Thase ME, Demyttenaere K, Earley WR, Gustafsson U, Udd M, Eriksson H.

Depress Anxiety. 2012 Jul;29(7):574-86. doi: 10.1002/da.21970. Epub 2012 Jul 2.

PMID:
22753280
13.

Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.

Maneeton N, Maneeton B, Srisurapanont M, Martin SD.

BMC Psychiatry. 2012 Sep 27;12:160. doi: 10.1186/1471-244X-12-160.

14.

Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.

Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H; Moonstone Study Group.

CNS Spectr. 2009 Jun;14(6):299-313.

PMID:
19668121
15.

Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline.

Bandelow B, Bauer M, Vieta E, El-Khalili N, Gustafsson U, Earley WR, Eriksson H.

World J Biol Psychiatry. 2014 Feb;15(2):155-66. doi: 10.3109/15622975.2013.842654.

PMID:
24506289
16.

Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder.

Vieta E, Bauer M, Montgomery S, McIntyre RS, Szamosi J, Earley WR, Eriksson H.

J Affect Disord. 2013 Sep 5;150(2):639-43. doi: 10.1016/j.jad.2013.01.052. Epub 2013 Mar 14.

PMID:
23497790
17.

Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.

Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D.

Clin Ther. 2011 Nov;33(11):1643-58. doi: 10.1016/j.clinthera.2011.10.002. Epub 2011 Nov 4.

PMID:
22054797
18.

Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder.

Mezhebovsky I, Mägi K, She F, Datto C, Eriksson H.

Int J Geriatr Psychiatry. 2013 Jun;28(6):615-25. doi: 10.1002/gps.3867. Epub 2012 Oct 16.

PMID:
23070803
19.

Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.

Bauer M, Thase ME, Liu S, Earley W, Eriksson H.

J Psychopharmacol. 2015 May;29(5):565-74. doi: 10.1177/0269881114552715. Epub 2014 Sep 25.

PMID:
25257148
20.

Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression.

Suppes T, Datto C, Minkwitz M, Nordenhem A, Walker C, Darko D.

J Affect Disord. 2010 Feb;121(1-2):106-15. doi: 10.1016/j.jad.2009.10.007. Epub 2009 Nov 8. Erratum in: J Affect Disord. 2014 Oct 15;168:484. Corrected and republished in: J Affect Disord. 2014 Oct;168:485-93.

PMID:
19903574

Supplemental Content

Support Center